BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1683122)

  • 1. RGD-containing peptides of VP1 of foot-and-mouth disease virus (FMDV) prevent virus infection in vitro.
    Liebermann H; Dölling R; Schmidt D; Thalmann G
    Acta Virol; 1991 Jan; 35(1):90-3. PubMed ID: 1683122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of anti foot and mouth disease virus T and B cell responses in cattle immunized with a peptide representing ten amino acids of VP1.
    Zamorano PI; Wigdorovitz A; Pérez Filgueira DM; Escribano JM; Sadir AM; Borca MV
    Vaccine; 1998 Apr; 16(6):558-63. PubMed ID: 9569465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif.
    Brown F; Benkirane N; Limal D; Halimi H; Newman JF; Van Regenmortel MH; Briand JP; Muller S
    Vaccine; 1999 Aug; 18(1-2):50-6. PubMed ID: 10501234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antigenic structure of the foot-and-mouth virus. VI. Functional segments of the immunodominant region of the VP1 protein of foot-and-mouth virus strains O1K and A22].
    Gel'famov VM; Grechaninova LA; Kan ES; Iarov AV; Surovoĭ AIu; Vol'pina OM; Chepurkin AV; Ivanov VT
    Bioorg Khim; 1991 May; 17(5):596-605. PubMed ID: 1722673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synthesis and immunogenic properties of peptides--fragments of the immunodominant regions of the VP1 protein of the Asia-1 type of foot- and-mouth disease virus].
    Petrov VN; Rybakov SS; Petrova ON; Chepurkin AV; Gulenkin VM
    Bioorg Khim; 1998 Dec; 24(12):899-905. PubMed ID: 10079947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure of an immunodominant loop on foot and mouth disease virus, serotype O1, determined under reducing conditions.
    Rowlands D; Logan D; Abu-Ghazaleh R; Blakemore W; Curry S; Jackson T; King A; Lea S; Lewis R; Newman J
    Arch Virol Suppl; 1994; 9():51-8. PubMed ID: 8032279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid).
    Fox G; Parry NR; Barnett PV; McGinn B; Rowlands DJ; Brown F
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():625-37. PubMed ID: 2543752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic properties and population stability of a foot-and-mouth disease virus with an altered Arg-Gly-Asp receptor-recognition motif.
    Ruiz-Jarabo CM; Sevilla N; Dávila M; Gómez-Mariano G; Baranowski E; Domingo E
    J Gen Virol; 1999 Aug; 80 ( Pt 8)():1899-1909. PubMed ID: 10466785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage.
    Baranowski E; Ruiz-Jarabo CM; Sevilla N; Andreu D; Beck E; Domingo E
    J Virol; 2000 Feb; 74(4):1641-7. PubMed ID: 10644333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is the Arg-Gly-Asp sequence the site for foot-and-mouth disease virus binding with cell receptor?].
    Surovoĭ AIu; Ivanov VT; Chepurkin AV; Ivaniushchenkov VN; Driagalin NN
    Bioorg Khim; 1988 Jul; 14(7):965-8. PubMed ID: 2847760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection conferred by TrpE fusion proteins containing portions of the C-terminal region of capsid protein VP1 of foot-and-mouth disease virus.
    Giavedoni LD; Kaplan G; Marcovecchio F; Piccone ME; Palma EL
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():967-71. PubMed ID: 1849980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice.
    Zamorano P; Wigdorovitz A; Perez-Filgueira M; Carrillo C; Escribano JM; Sadir AM; Borca MV
    Virology; 1995 Oct; 212(2):614-21. PubMed ID: 7571431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid changes outside the G-H loop of capsid protein VP1 of type O foot-and-mouth disease virus confer resistance to neutralization by antipeptide G-H serum.
    Krebs O; Ahl R; Straub OC; Marquardt O
    Vaccine; 1993; 11(3):359-62. PubMed ID: 7680514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of substituted and tandem-repeated peptides to probe the relevance of the highly conserved RGD tripeptide in the immune response against foot-and-mouth disease virus.
    Novella IS; Borrego B; Mateu MG; Domingo E; Giralt E; Andreu D
    FEBS Lett; 1993 Sep; 330(3):253-9. PubMed ID: 7690714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway.
    Mason PW; Rieder E; Baxt B
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1932-6. PubMed ID: 8127909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural comparison of two strains of foot-and-mouth disease virus subtype O1 and a laboratory antigenic variant, G67.
    Lea S; Abu-Ghazaleh R; Blakemore W; Curry S; Fry E; Jackson T; King A; Logan D; Newman J; Stuart D
    Structure; 1995 Jun; 3(6):571-80. PubMed ID: 8590018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antigenic structure of the foot-and-mouth disease virus. III. Immunogenic properties of synthetic peptides of the sequence of the immunodominant region of VP1 proteins of the O1K and A22 strains of foot-and-mouth virus].
    Surovoĭ AIu; Gel'fanov VM; Vol'pina OM; Ivanov VT; Chepurkin AV; Chepurkin AV; Ivaniushchenkov VM; Driagalin NN; Burdov AN
    Bioorg Khim; 1989 Sep; 15(9):1185-92. PubMed ID: 2480134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of B and T cell epitopes by cattle immunized with a synthetic peptide containing the major immunogenic site of VP1 FMDV 01 Campos.
    Zamorano P; Wigdorovitz A; Chaher MT; Fernandez FM; Carrillo C; Marcovecchio FE; Sadir AM; Borca MV
    Virology; 1994 Jun; 201(2):383-7. PubMed ID: 8184548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of synthetic peptides for detection of antibodies against foot-and-mouth disease virus in the blood from convalescent animals].
    Petrov VN; Rybakov SS; Petrova ON; Lugovskoĭ AA; Pavlov AV
    Mol Gen Mikrobiol Virusol; 1996; (3):27-31. PubMed ID: 8999315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point mutations within the betaG-betaH loop of foot-and-mouth disease virus O1K affect virus attachment to target cells.
    Leippert M; Beck E; Weiland F; Pfaff E
    J Virol; 1997 Feb; 71(2):1046-51. PubMed ID: 8995624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.